SLPI antibody
Quick Overview for SLPI antibody (ABIN6757675)
Target
See all SLPI AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Specificity
- Recognizes human SLPI in direct ELISA and Western Blot. ~20 % cross-reactivity with mSLPI (ELISA). Antibody neutralizes SLPI biological activity.
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Purified, E. coli-derived, recombinant human secretory leukocyte protease inhibitor (SLPI).
Type of Immunogen: Recombinant protein -
Isotype
- IgG
-
-
-
-
Application Notes
-
Approved: ELISA (0.5 - 1 μg/mL), Neut, WB (0.1 - 0.2 μg/mL)
Usage: Suitable for use in Neutralization, Direct ELISA, Western Blot. Neutralization: ~20 ng of antibody will neutralize 50 % of the activity due to 1 ng of rhSLPI. Inhibits trypsin-catalyzed hydrolysis of tosyl-Gly-Pro-Lys-4-nitroanilide acetate. Recombinant human SLPI will inhibit trypsin activity at a 1:1 Molar ratio of rhSLPI to active trypsin. Direct ELISA: 0.5-1.0 μg/mL. The detection limit for rhSLPI is approximately 0.03 ng/well. Western Blot: 0.1-0.2 μg/mL with the appropriate secondary reagents to detect human SLPI. The detection limit for rhSLPI is ~1 ng/lane under non-reducing and reducing conditions. -
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.2, 40 % glycerol.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Short term: 4°C
Long term: Add glycerol (40-50%) -20°C.
-
-
- SLPI (Secretory Leukocyte Peptidase Inhibitor (SLPI))
-
Alternative Name
- ALK1 / SLPI
-
Background
-
Name/Gene ID: SLPI
Synonyms: SLPI, ALK1, ALP, Antileukoprotease, BLPI, HUSI, Mucus proteinase inhibitor, HUSI-I, SLP1, Antileukoproteinase, Seminal proteinase inhibitor, WFDC4, HUSI-1, Protease inhibitor WAP4, WAP4 -
Gene ID
- 6590
-
UniProt
- P03973
Target
-